- Activity pressure is positive on the latest completed week.
600436
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Zhangzhou Pientzehuang Pharmaceutical., Ltd. · Healthcare · Drug Manufacturers - General
Latest close
137.0 CNY
-1.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -4.2% below the Trend Line and sits at 27.4% of its 52-week range. The latest completed week returned -1.8%, after a 18.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
36
out of 100
Latest Close
137.0 CNY
7 Aug 2026
1W Return
-1.8%
latest completed week
4W Return
18.4%
short-term follow-through
12W Return
1.2%
quarterly tape
Trend Breadth
1.9%
1 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 37.70% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.8%
Latest completed week; four-week move 18.4%.
Indicator stack
1/85
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.70%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -4.2% below the Trend Line and sits at 27.4% of its 52-week range. The latest completed week returned -1.8%, after a 18.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 18.4% over four weeks, 1.2% over 12 weeks, and -31.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year1
Trend breadth1.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.08Latest activity-pressure read.
Pressure change188.6%Four-week change in activity pressure.
Leadership-15.09Latest relative-leadership reading.
RS change52.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-36.9%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2619 weeks finished lower.
Best week+25.3%Week of 17 Jul.
Worst week-11.1%Week of 24 Jul.
Latest week-1.8%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains3
Flat weeks0
Modest losses13
Sharp losses6
Recent vol9.0%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split15/37Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank7 / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Drug Manufacturers - General
4-week rank1 / 22
Group average3.7%
Trend breadth9.1%
Trend9.1%active weekly trend signals
MD40.9%positive activity pressure
RS18.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 37.70%Next-week expectancy is negative with a 37.70% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Price to book ratio of Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A – SSE:600436 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 137.0 CNY | -1.8% | 143.0 CNY | 200.9 CNY | 1.08 | -15.09 | 31.7M | Off |
| 31 Jul 2026 | 139.4 CNY | 8.2% | 144.1 CNY | 201.7 CNY | 0.69 | -12.01 | 38.0M | Off |
| 24 Jul 2026 | 128.8 CNY | -11.1% | 145.1 CNY | 202.6 CNY | 0.08 | -19.06 | 68.5M | Off |
| 17 Jul 2026 | 145.0 CNY | 25.3% | 146.6 CNY | 203.5 CNY | -0.59 | -8.62 | 79.2M | Off |
| 10 Jul 2026 | 115.7 CNY | 2.5% | 147.4 CNY | 204.4 CNY | -1.22 | -31.82 | 23.0M | Off |
| 3 Jul 2026 | 112.9 CNY | 5.7% | 149.2 CNY | 205.4 CNY | -1.48 | -35.06 | 4.6M | Off |
| 26 Jun 2026 | 106.8 CNY | -5.4% | 151.2 CNY | 206.5 CNY | -1.57 | -39.14 | 3.6M | Off |
| 19 Jun 2026 | 112.9 CNY | -5.6% | 153.5 CNY | 207.6 CNY | -1.45 | -37.53 | 12.6M | Off |
| 12 Jun 2026 | 119.6 CNY | -1.6% | 155.8 CNY | 208.8 CNY | -1.39 | -33.77 | 4.3M | Off |
| 5 Jun 2026 | 121.5 CNY | -5.4% | 157.6 CNY | 209.9 CNY | -1.28 | -33.48 | 3.1M | Off |
| 29 May 2026 | 128.4 CNY | 3.5% | 159.5 CNY | 211.0 CNY | -1.18 | -31.26 | 24.6M | Off |
| 22 May 2026 | 124.1 CNY | -8.3% | 161.3 CNY | 212.1 CNY | -1.21 | -35.08 | 19.9M | Off |
| 15 May 2026 | 135.3 CNY | -4.2% | 163.7 CNY | 213.0 CNY | -1.27 | -30.48 | 15.3M | Off |
| 8 May 2026 | 141.2 CNY | -1.7% | 165.7 CNY | 213.8 CNY | -1.29 | -29.06 | 9.9M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.